Table of Content

1 Biologics and Biosimilars Market Introduction and Overview
1.1 Biologics and Biosimilars Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Biologics and Biosimilars Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Biologics and Biosimilars Revenue and Market Share by Type
3 Global Biologics and Biosimilars Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Biologics and Biosimilars Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Biologics and Biosimilars Market Size (2019-2024)
4.2 Biologics and Biosimilars Growth Trends Analysis by Regions
4.2.1 Biologics and Biosimilars Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Biologics and Biosimilars Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Biologics and Biosimilars Market Size (2019-2024)
4.2.4 Europe Biologics and Biosimilars Market Size (2019-2024)
4.2.5 Asia-Pacific Biologics and Biosimilars Market Size (2019-2024)
4.2.6 Latin America Biologics and Biosimilars Market Size (2019-2024)
4.2.7 Middle East & Africa Biologics and Biosimilars Market Size (2019-2024)
5 North America
5.1 North America Biologics and Biosimilars Revenue by Countries
5.1.1 North America Biologics and Biosimilars Revenue by Countries (2019-2024)
5.2 North America Biologics and Biosimilars Revenue by Types
5.3 North America Biologics and Biosimilars Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Biologics and Biosimilars Revenue by Countries
6.1.1 Asia Pacific Biologics and Biosimilars Revenue by Countries (2019-2024)
6.2 Asia Pacific Biologics and Biosimilars Revenue by Types
6.3 Asia Pacific Biologics and Biosimilars Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics and Biosimilars Revenue by Countries
7.1.1 Europe Biologics and Biosimilars Revenue by Countries (2019-2024)
7.2 Europe Biologics and Biosimilars Revenue by Types
7.3 Europe Biologics and Biosimilars Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Biologics and Biosimilars Revenue by Countries
8.1.1 Latin America Biologics and Biosimilars Revenue by Countries (2019-2024)
8.2 Latin America Biologics and Biosimilars Revenue by Types
8.3 Latin America Biologics and Biosimilars Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Biologics and Biosimilars Revenue by Countries
9.1.1 Middle East & Africa Biologics and Biosimilars Revenue by Countries (2019-2024)
9.2 Middle East & Africa Biologics and Biosimilars Revenue by Types
9.3 Middle East & Africa Biologics and Biosimilars Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Biologics and Biosimilars Market Competition, by Players
10.1 Global Biologics and Biosimilars Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Biologics and Biosimilars Players Market Share in 2023
10.2.2 Top 6 Biologics and Biosimilars Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Biologics and Biosimilars Players Head Office, Business Provided
10.4 Biologics and Biosimilars Mergers & Acquisitions
10.5 Biologics and Biosimilars New Entrants and Expansion Plans
11 Players Profiles11.1 Roche
11.1.1 Roche Company Profile
11.1.2 Biologics and Biosimilars Product Overview
11.1.3 Roche Biologics and Biosimilars Market Performance (2019-2024)
11.1.4 Roche Business Overview
11.1.5 Recent Developments and Plans
11.2 Amgen
11.2.1 Amgen Company Profile
11.2.2 Biologics and Biosimilars Product Overview
11.2.3 Amgen Biologics and Biosimilars Market Performance (2019-2024)
11.2.4 Amgen Business Overview
11.2.5 Recent Developments and Plans
11.3 AbbVie
11.3.1 AbbVie Company Profile
11.3.2 Biologics and Biosimilars Product Overview
11.3.3 AbbVie Biologics and Biosimilars Market Performance (2019-2024)
11.3.4 AbbVie Business Overview
11.3.5 Recent Developments and Plans
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Profile
11.4.2 Biologics and Biosimilars Product Overview
11.4.3 Sanofi-Aventis Biologics and Biosimilars Market Performance (2019-2024)
11.4.4 Sanofi-Aventis Business Overview
11.4.5 Recent Developments and Plans
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Profile
11.5.2 Biologics and Biosimilars Product Overview
11.5.3 Johnson & Johnson Biologics and Biosimilars Market Performance (2019-2024)
11.5.4 Johnson & Johnson Business Overview
11.5.5 Recent Developments and Plans
11.6 Pfizer
11.6.1 Pfizer Company Profile
11.6.2 Biologics and Biosimilars Product Overview
11.6.3 Pfizer Biologics and Biosimilars Market Performance (2019-2024)
11.6.4 Pfizer Business Overview
11.6.5 Recent Developments and Plans
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Profile
11.7.2 Biologics and Biosimilars Product Overview
11.7.3 Novo Nordisk Biologics and Biosimilars Market Performance (2019-2024)
11.7.4 Novo Nordisk Business Overview
11.7.5 Recent Developments and Plans
11.8 Eli Lilly
11.8.1 Eli Lilly Company Profile
11.8.2 Biologics and Biosimilars Product Overview
11.8.3 Eli Lilly Biologics and Biosimilars Market Performance (2019-2024)
11.8.4 Eli Lilly Business Overview
11.8.5 Recent Developments and Plans
11.9 Novartis
11.9.1 Novartis Company Profile
11.9.2 Biologics and Biosimilars Product Overview
11.9.3 Novartis Biologics and Biosimilars Market Performance (2019-2024)
11.9.4 Novartis Business Overview
11.9.5 Recent Developments and Plans
11.10 Merck
11.10.1 Merck Company Profile
11.10.2 Biologics and Biosimilars Product Overview
11.10.3 Merck Biologics and Biosimilars Market Performance (2019-2024)
11.10.4 Merck Business Overview
11.10.5 Recent Developments and Plans
12 Global Biologics and Biosimilars Forecast Market Analysis by Type
12.1 Global Biologics and Biosimilars Revenue Market Forecast by Type (2024-2030)
13 Global Biologics and Biosimilars Forecast Market Analysis by Application
13.1 Biologics and Biosimilars Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Biologics and Biosimilars Forecast Market Size (2024-2030)
14.2 Biologics and Biosimilars Growth Trends Forecast Analysis by Regions
14.2.1 Biologics and Biosimilars Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Biologics and Biosimilars Forecast Market Size (2024-2030)
14.2.3 Europe Biologics and Biosimilars Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Biologics and Biosimilars Forecast Market Size (2024-2030)
14.2.5 Latin America Biologics and Biosimilars Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Biologics and Biosimilars Forecast Market Size (2024-2030)
15 Biologics and Biosimilars Industry Dynamic Analysis
15.1 Biologics and Biosimilars Market Trends Analysis
15.2 Biologics and Biosimilars Market Drivers Analysis
15.3 Biologics and Biosimilars Market Challenges Analysis
15.4 Biologics and Biosimilars Market Restraints Analysis